---
title: "Crispr Therapeutics Is Maintained at Buy by Truist Securities"
date: "2025-02-13 01:38:00"
summary: "(17:38 GMT) Crispr Therapeutics Price Target Raised to $120.00/Share From $100.00 by Truist Securities"
categories:
  - "Dow Jones Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Dow Jones Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

**(17:38 GMT)** Crispr Therapeutics Price Target Raised to $120.00/Share From $100.00 by Truist Securities

[Dow Jones Newswires](https://www.tradingview.com/news/DJN_DN20250212010915:0/)
